Amgen, Horizon Say FTC Merger Challenge 'Defies Logic'
Amgen and Horizon Therapeutics urged an Illinois federal judge not to let the Federal Trade Commission block their planned $27.8 billion merger, arguing in a brief unsealed Tuesday that FTC fears...To view the full article, register now.
Already a subscriber? Click here to view full article